Active substanceTaurineTaurine
Similar drugsTo uncover
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Igrele®
    drops d / eye 
    KVADRAT-S, LLC     Russia
  • CardioActiv® Taurine
    pills inwards 
    EVALAR, CJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Taurine
    drops d / eye 
    VIFITEH, CJSC     Russia
  • Taurine
    solution
    DALHIMFARM, OJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Firm VIPS-MED, LLC     Russia
  • Taurine
    films d / eye 
    Progress RCC, JSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Company DEKO, LLC     Russia
  • Taurine
    drops d / eye 
  • Taurin-Akos
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Taurin-DIA
    drops d / eye 
  • Taurin-SOLOFARM
    drops d / eye 
    GROTEKS, LLC     Russia
  • Taufon
    drops d / eye 
  • Dosage form: & nbspeye drops
    Composition:

    in 1 ml of the drug contains:

    Active substance: taurine 40 mg

    Excipients: methyusharahydroxybenzoate (nipagin), water for injections

    Description:colorless transparent liquid
    Pharmacotherapeutic group:metabolic
    ATX: & nbsp

    S.01.X.A   Other drugs for the treatment of eye diseases

    C.01.E.B   Other drugs for the treatment of heart disease

    Pharmacodynamics:

    An anticancer agent, it has a metabolic effect.

    Taurine is a sulfur-containing amino acid that forms in the body during the conversion of cysteine. Stimulates the processes of repair and regeneration in diseases of a dystrophic nature and diseases accompanied by a sharp disruption of the metabolism of the eye tissues.

    It promotes the normalization of the functions of cell membranes, the activation of energy and metabolic processes, the preservation of the electrolyte composition of the cytoplasm due to the accumulation of K+ and Ca2+, improving the conditions for carrying out a nerve impulse.

    Pharmacokinetics:With topical application, systemic absorption is low.
    Indications:

    Dystrophy of the cornea; cataracts (senile, diabetic, traumatic, radiation); trauma of the cornea (as a stimulant of reparative processes).

    Contraindications:Individual hypersensitivity to the components of the drug, children under 18 years of age.
    Carefully:
    Pregnancy and lactation:

    Sufficient experience in the use of the drug during pregnancy, breast-feeding is not.Possible use of Taurine for the treatment of pregnant and lactating mothers bythe appointment of a doctor if the expected effect exceeds the risk of possible side effects.

    Dosing and Administration:

    With cataract Taurine Assign in the form of instillations 1-2 drops 2-4 times a day for 3 months. The course is repeated at a monthly interval.

    With injuries and dystrophic diseases of the cornea Taurine apply in the same doses for 1 month.

    Side effects:Allergic reactions.
    Overdose:

    Data on overdose are absent.

    Interaction:Data on the interaction of Taurine with other drugs are absent.
    Special instructions:
    Form release / dosage:

    Eye drops 4%. For 5 or 10 ml in polyethylene bottles, hermetically sealed with stoppers, droppers and caps screwed.

    Each bottle, together with the instructions for use, is placed in a pack of cardboard.

    50 bottles and 50 instructions for use are placed in a box of cardboard (for inpatient).

    Packaging:(1) - bottle-dropper polyethylene (1) - packs cardboard
    (1) - bottle-dropper polyethylene (50) - cardboard boxes
    Storage conditions:

    In a dry, dark place at a temperature of 8 ° C to 20 ° C.

    Keep out of the reach of children.
    Shelf life:3 years. Do not use after expiry date.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-004697/09
    Date of registration:10.06.2009
    The owner of the registration certificate:Firm VIPS-MED, LLC Firm VIPS-MED, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp05.09.2015
    Illustrated instructions
      Instructions
      Up